CURRENT OPINION IN HEMATOLOGY

CURRENT OPINION IN HEMATOLOGY

CURR OPIN HEMATOL
影响因子:2.9
是否综述期刊:
是否预警:不在预警名单内
是否OA:
出版国家/地区:UNITED STATES
出版社:Lippincott Williams and Wilkins Ltd.
发刊时间:0
发刊频率:Bimonthly
收录数据库:SCIE/Scopus收录
ISSN:1065-6251

期刊介绍

Current Opinion in Hematology is an easy-to-digest bimonthly journal covering the most interesting and important advances in the field of hematology. Its hand-picked selection of editors ensure the highest quality selection of unbiased review articles on themes from nine key subject areas, including myeloid biology, Vascular biology, hematopoiesis and erythroid system and its diseases.
《血液学的最新观点》是一本易于消化的双月刊杂志,涵盖了血液学领域最有趣和最重要的进展。其精心挑选的编辑确保了最高质量的无偏见的审查文章的主题从九个关键领域,包括骨髓生物学,血管生物学,造血和红细胞系统及其疾病。
年发文量 41
国人发稿量 1.32
国人发文占比 0.03%
自引率 -
平均录取率0
平均审稿周期 较慢,6-12周
版面费 -
偏重研究方向 医学-血液学
期刊官网 http://journals.lww.com/co-hematology/pages/default.aspx
投稿链接 https://www.editorialmanager.com/COH

期刊高被引文献

New insights into the links between hypoxia and iron homeostasis
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000494
Neutropenia in glycogen storage disease Ib: outcomes for patients treated with granulocyte colony-stimulating factor
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000474
Neutropenia in Barth syndrome: characteristics, risks, and management
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000472
PIK3CA mutations in vascular malformations
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000496
Rapamycin and treatment of venous malformations.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000498
Altered functions of platelets during aging.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000526
Mechanisms of leukemic transformation in congenital neutropenia
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000479
p53 involvement in clonal hematopoiesis of indeterminate potential.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000509
Why are hypomethylating agents or low-dose cytarabine and venetoclax so effective?
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000485
The future of cell-free DNA testing to guide therapeutic decisions in B-cell lymphomas.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000516
Outpatient induction and consolidation care strategies in acute myeloid leukemia
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000481
Toll-like receptor signaling in hematopoietic stem and progenitor cells.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000511
CADASIL: new advances in basic science and clinical perspectives
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000497
The role of CXCR2 in acute inflammatory responses and its antagonists as anti-inflammatory therapeutics
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000476
Deregulation of Drosha in the pathogenesis of hereditary hemorrhagic telangiectasia
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000493
Emerging single-cell tools are primed to reveal functional and molecular heterogeneity in malignant hematopoietic stem cells.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000512
Normal and leukemic stem cell niche interactions.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000508
Luke Fletcher, md1,2 and uma borate, md1,2.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000486
Using genomic data for selecting the treatment of lymphoma patients.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000520
Emerging molecular mechanisms of vascular dementia
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000502
A somatic missense mutation in GNAQ causes capillary malformation
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000500
Oxidation and erythropoiesis
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000495
Shifting therapeutic paradigms in induction and consolidation for older adults with acute myeloid leukemia
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000480
Registries for study of nonmalignant hematological diseases: the example of the Severe Chronic Neutropenia International Registry.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000558
Banking with precision: transfusion medicine as a potential universal application in clinical genomics.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000536
Bone morphogenetic protein and blood vessels: new insights into endothelial cell junction regulation
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000492
Application of stem cell transplantation to autoimmune diseases.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000531
Does fibrinogen serve the host or the microbe in Staphylococcus infection?
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000527
Transcription factor and cytokine regulation of eosinophil lineage commitment.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000552
Which patients with acute myeloid leukemia in CR1 can be spared an allogeneic transplant?
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000482
Posttransplant maintenance therapy for acute leukemias
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000484
Current landscape for chimeric antigen receptor T cells in lymphomas.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000544
Antiphospholipid syndrome in pediatric patients.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000523
Hypomethylating agents with venetoclax: have we discovered the holy grail?
来源期刊:Current opinion in hematologyDOI:10.1097/moh.0000000000000560
The controversial role of red cell transfusions for sickle cell pain.
来源期刊:Current opinion in hematologyDOI:10.1097/moh.0000000000000537
Recent advances in inherited platelet disorders.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000525
Current state of nonengrafting donor leukocyte infusion (focus on microtransplantation for acute myeloid leukemia).
来源期刊:Current opinion in hematologyDOI:10.1097/moh.0000000000000539
MICROtransplant to refractory acute myeloid leukemia in Egyptian population.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000547
Detection and management of acute myeloid leukemia measurable residual disease: is it standard of care?
来源期刊:Current opinion in hematologyDOI:10.1097/moh.0000000000000566
Hematopoietic stem cells: self-renewal and expansion.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000506
Defining the functions of adenosine-to-inosine RNA editing through hematology.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000514
Novel tyrosine kinase inhibitors for patients with inadequate response in chronic myeloid leukemia
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000489
Strategies for managing transfusional iron overload: conventional treatments and novel strategies
来源期刊:Current Opinion in HematologyDOI:10.1097/MOH.0000000000000499
Activated protein C in neuroprotection and malaria.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000528
Is autologous stem cell transplantation still relevant for multiple myeloma?
来源期刊:Current opinion in hematologyDOI:10.1097/moh.0000000000000538
Using minimal (measurable) residual disease assessments to guide decision-making for timing of allogeneic transplantation in acute myeloid leukemia.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000543
Editorial introduction.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000487
Growing old in the age of heterogeneity: the perils of shifting clonality.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000513
Genetic and epigenetic factors interacting with clonal hematopoiesis resulting in chronic myelomonocytic leukemia.
来源期刊:Current opinion in hematologyDOI:10.1097/MOH.0000000000000553

质量指标占比

研究类文章占比 OA被引用占比 撤稿占比 出版后修正文章占比
73.17%9.73%--

相关指数

影响因子
影响因子
年发文量
自引率
Cite Score

预警情况

查看说明
时间 预警情况
2025年03月发布的2025版不在预警名单中
2024年02月发布的2024版不在预警名单中
2023年01月发布的2023版不在预警名单中
2021年12月发布的2021版不在预警名单中
2020年12月发布的2020版不在预警名单中
*来源:中科院《 国际期刊预警名单》

JCR分区

WOS分区等级:Q2区
版本 按学科 分区
WOS期刊SCI分区
WOS期刊SCI分区
WOS期刊SCI分区是指SCI官方(Web of Science)为每个学科内的期刊按照IF数值排 序,将期刊按照四等分的方法划分的Q1-Q4等级,Q1代表质量最高,即常说的1区期刊。
(2024-2025年最新版)
HEMATOLOGY
Q2

中科院分区

查看说明
版本 大类学科 小类学科 Top期刊 综述期刊
2025年3月最新升级版
医学4区
HEMATOLOGY 血液学
3区
2023年12月升级版
医学3区
HEMATOLOGY 血液学
4区
2022年12月旧的升级版
医学3区
HEMATOLOGY 血液学
3区